IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 27 filers reported holding IMMUCELL CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $77,600 | -8.5% | 16,000 | 0.0% | 0.03% | -6.9% |
| Q1 2024 | $84,800 | +4.1% | 16,000 | 0.0% | 0.03% | -3.3% |
| Q4 2023 | $81,440 | -4.7% | 16,000 | 0.0% | 0.03% | -16.7% |
| Q3 2023 | $85,438 | +6.8% | 16,000 | 0.0% | 0.04% | +9.1% |
| Q2 2023 | $80,000 | -2.2% | 16,000 | 0.0% | 0.03% | -8.3% |
| Q1 2023 | $81,760 | -31.9% | 16,000 | 0.0% | 0.04% | -42.9% |
| Q3 2022 | $120,000 | -13.7% | 16,000 | +6.7% | 0.06% | -11.3% |
| Q2 2022 | $139,000 | -4.1% | 15,000 | 0.0% | 0.07% | 0.0% |
| Q1 2022 | $145,000 | +20.8% | 15,000 | 0.0% | 0.07% | +16.4% |
| Q4 2021 | $120,000 | -14.3% | 15,000 | 0.0% | 0.06% | -19.7% |
| Q3 2021 | $140,000 | -2.1% | 15,000 | 0.0% | 0.08% | -14.6% |
| Q2 2021 | $143,000 | -1.4% | 15,000 | 0.0% | 0.09% | -13.6% |
| Q1 2021 | $145,000 | +62.9% | 15,000 | 0.0% | 0.10% | +37.3% |
| Q4 2020 | $89,000 | – | 15,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 101,594 | $523,717 | 0.11% |
| Empire Financial Management Company, LLC | 42,000 | $214,620 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 29,675 | $151,639 | 0.08% |
| Minerva Advisors LLC | 11,958 | $61,105 | 0.04% |
| Overbrook Management Corp | 32,857 | $167,899 | 0.04% |
| WEALTH EFFECTS LLC | 15,667 | $80,058 | 0.04% |
| Prosperity Planning, Inc. | 16,000 | $81,760 | 0.04% |
| SHUFRO ROSE & CO LLC | 62,408 | $318,905 | 0.03% |
| Strategic Financial Services, Inc. | 31,000 | $159,650 | 0.01% |
| Cresset Asset Management, LLC | 100,506 | $517,606 | 0.01% |